Repurposing dimethyl fumarate for cancer therapy: current evidence and future directions.

Front Pharmacol · 2025 · PMC12702882 · PMID 41403438

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

While its effect on neutropenia was limited under standard dosing, a modified regimen with pre-treatment showed a trend toward hematologic protection and even reduced vibrissae loss.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.